Latest Biotech News

The FDA’s Center for Devices and Radiological Health issued draft guidance focused on cuffless blood‑pressure monitoring devices, signaling tighter oversight as over‑the‑counter, cuffless products...

Moderna is curbing investments in late‑stage vaccine trials following backlash in the U.S., according to reporting that cited the company’s CEO. The move reflects mounting political and public...

A new JCVI spinout, Diploid Genomics, cofounded by J. Craig Venter, launched with seed funding from Healthier Capital to build an AI‑driven genomics analytics platform for research and...

Erasca closed an upsized public offering, selling 25,875,000 shares at $10.00 each and generating approximately $258.8 million in gross proceeds. The company said all shares were sold by Erasca...

Corxel Pharmaceuticals completed a $287 million Series D to fund global development of CX‑11, an oral small‑molecule GLP‑1 receptor agonist for obesity and overweight patients. The financing will...

Mendra secured $82 million in Series A financing to build a company focused on acquiring, developing and commercializing therapies for rare diseases. The round, co‑led by OrbiMed, 8VC and 5AM...

NVIDIA and Eli Lilly announced a $1 billion partnership to create an AI‑powered drug discovery laboratory in the San Francisco Bay Area. The collaboration combines NVIDIA’s computing platforms and...

Sanofi said it will pursue global regulatory submissions for amlitelimab in atopic dermatitis based on the totality of data even though additional phase III results showed mixed outcomes across...

Encodia, a San Diego firm developing DNA‑tagged peptide protein sequencing (ProteoCode), has ceased operations and moved to liquidate laboratory equipment, according to reports and a former...

Cellular Origins and Fresenius Kabi completed the first phase of their collaboration to scale cell and gene therapy manufacturing by integrating Fresenius Kabi’s Cue R cell processing system into...

Researchers at the Icahn School of Medicine at Mount Sinai reported preclinical data showing IL‑12–producing CAR T cells that target tumor‑associated macrophages (TAMs) remodel the tumor...

The J. Craig Venter Institute announced the launch of Diploid Genomics, an AI‑driven genomics analytics spinout co‑founded by J. Craig Venter with seed investment from Healthier Capital. Diploid...

The European Union unveiled FAST‑EU, a voluntary pilot intended to accelerate the start‑up timeline for multinational clinical trials with a maximum 70‑day (10‑week) timeline from sponsor...

NVIDIA and Eli Lilly announced a $1 billion partnership to build an AI-powered drug discovery laboratory aimed at accelerating biologics and small‑molecule discovery. The collaboration will pair...

Bristol Myers Squibb struck a collaboration with Janux Therapeutics to develop tumor‑activated T‑cell engagers, paying $50 million up front and creating up to ~$850 million in potential payments....

Corxel Pharmaceuticals closed a $287 million Series D to advance its oral GLP‑1 receptor agonist CX‑11 through pivotal development and expand global trials. The financing will support U.S. Phase...

Diploid Genomics launched as a JCVI spinout led by J. Craig Venter, backed by Healthier Capital, to commercialize AI‑driven genomics analytics for research and diagnostics. The company plans to...

Sanofi said it will pursue global regulatory submissions for amlitelimab in atopic dermatitis despite mixed Phase III results that produced divergent outcomes under U.S. and EU analyses. One trial...

Moderna's leadership signaled cuts to investments in late‑stage infectious disease vaccine trials after facing political and public backlash in the U.S. Executives told media the company will...

Erasca closed an upsized public offering that raised approximately $258.8 million to fund its RAS/MAPK pathway oncology programs. The clinical‑stage precision oncology company said all shares were...